US EditionSinoMed Surges as FDA Grants Breakthrough Status to New Stent System
Summary by Digital Phablet
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
SinoMed Surges as FDA Grants Breakthrough Status to New Stent System
Shares of a Chinese medical technology company soared to their maximum daily trading limit after announcing that the U.S. Food and Drug Administration had granted Breakthrough Device Designation to two of its medical devices. Among these is the world’s first stent system designed specifically for treating intracranial atherosclerotic stenosis, offering renewed hope to millions worldwide who are recovering from strokes. The company’s stock closed…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
